Status:
ACTIVE_NOT_RECRUITING
Immunosurveillance for Metastatic Colorectal Cancer
Lead Sponsor:
MIPO Clinic
Conditions:
Monitoring, Immunologic
Eligibility:
All Genders
40-65 years
Phase:
PHASE1
PHASE2
Brief Summary
The goal of this study type: clinical trial is to primary purpose: e.g., learn if intervention or health behavior can treat, prevent, diagnose etc. and improve the quality of life and reduce one-year ...
Detailed Description
Materials and methods of the study. According to the approved by the Local Ethical Committee of the Kazakh National Medical University, it was planned to include in the study 200 patients from 19 regi...
Eligibility Criteria
Inclusion
- Oncological patients with a histologically confirmed diagnosis of "colorectal cancer" and regional metastases at stages T1-4 N1-2 M0, who have provided informed consent to participate in the study.
- Oncological patients with a histologically confirmed diagnosis of "colorectal cancer" with distant metastases at stages T1-4 N1-2 M1, who have provided informed consent to participate in the study.
Exclusion
- Oncological patients with a histologically confirmed diagnosis of "colorectal cancer" and regional metastases at stages T1-4 N1-2 M1, who have active forms of pulmonary tuberculosis, decompensated diabetes, decompensated cardiac, vascular, lung, liver, and renal failure.
- Oncological patients with a histologically confirmed diagnosis of "colorectal cancer" with regional and distant metastases at stages T1-4 N1-2 M1, who have not provided informed consent to participate in the study.
Key Trial Info
Start Date :
July 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06509880
Start Date
July 15 2024
End Date
July 31 2024
Last Update
July 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MIPOClinic
Almaty, Kazakhstan, 050038